Skip to main content

Advertisement

SpringerLink
Log in

Helix pomatia Agglutinin Binding Glycoproteins in Thyroid Tumors

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Binding of the lectin Helix pomatia agglutinin (HPA) has been shown to be associated with poor prognosis in many human cancers, but not in thyroid cancer. The aims of the present study were to assess alteration in cellular glycosylation, detected by HPA binding, in thyroid tumors; to determine if such altered glycosylation carries any prognostic significance; and to analyze qualitative and quantitative differences of HPA-binding glycoproteins in various thyroid tumors.

Methods

Lectin histochemistry was performed on 110 archival paraffin wax embedded specimens of various thyroid tumors excised between the years 1983–1993. Demographic data, histological data, and time to death were recorded, and multivariate Cox regression analysis was performed to determine a prognostic model for patient survival based on the data. Helix pomatia agglutinin binding glycoproteins were isolated from 128 fresh specimens of various thyroid tissues by affinity chromatography, analyzed by SDS-PAGE and western blotting.

Results

There was a marked qualitative difference in the profile of HPA-binding glycoproteins, with the malignant thyroid tumors showing a heterogeneous profile of numerous HPA binding glycoprotein bands. Lectin histochemistry showed significant positive HPA binding in malignant thyroid tumors (p = 0.0009). Kaplan–Meir survival analysis revealed that among patients who died of their disease those with HPA-positive tumors had a significantly shorter survival (p = 0.009).

Conclusions

This is the first study showing that HPA binding glycoproteins are synthesized by thyroid tumors. Thyroid cancers show a broader profile of HPA binding glycoproteins compared to benign thyroid tumors, and positive HPA binding is significantly associated with shorter survival and poorer prognosis in thyroid cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Brooks SA (2000) The involvement of Helix pomatia lectin (HPA) binding N-acetylgalactosamine glycans in cancer progression. Histol Histopathol 15:143–158

    PubMed  CAS  Google Scholar 

  2. Leathem AJ, Brooks SA (1987) Predictive value of lectin binding on breast-cancer recurrence and survival. Lancet 1(8541):1054–1056

    Article  PubMed  CAS  Google Scholar 

  3. Brooks SA, Leathem AJ (1991) Prediction of lymph node involvement in breast cancer by detection of altered glycosylation in the primary tumour. Lancet 338(8759):71–74

    Article  PubMed  CAS  Google Scholar 

  4. Fenlon S, Ellis IO, Bell J et al (1987) Helix pomatia and Ulex europeus lectin binding in human breast carcinoma. J Pathol 152:169–176

    Article  PubMed  CAS  Google Scholar 

  5. Alam SM, Whitford P, Cushley W et al (1990) Flow cytometric analysis of cell surface carbohydrates in metastatic human breast cancer. Br J Cancer 62:238–242

    Article  PubMed  CAS  Google Scholar 

  6. Noguchi M, Thomas M, Kitagawa H et al (1993) DNA ploidy and Helix pomatia lectin binding as predictors of regional lymph node metastases and prognostic factors in breast cancer. Breast Cancer Res Treat 26:67–75

    Article  PubMed  CAS  Google Scholar 

  7. Noguchi M, Thomas M, Kitagawa H et al (1993) Further analysis of predictive value of Helix pomatia lectin binding to primary breast cancer for axillary and internal mammary lymph node metastases. Br J Cancer 67:1368–1371

    Article  PubMed  CAS  Google Scholar 

  8. Kakeji Y, Tsujitani S, Mori M et al (1991) Helix pomatia agglutinin binding activity is a predictor of survival time for patients with gastric carcinoma. Cancer 68:2438–2442

    Article  PubMed  CAS  Google Scholar 

  9. Schumacher DU, Randall CJ, Ramsay AD et al (1996) Is the binding of the lectin Helix pomatia agglutinin (HPA) of prognostic relevance in tumours of the upper aerodigestive tract? Eur J Surg Oncol 22:618–620

    PubMed  CAS  Google Scholar 

  10. Schumacher U, Adam E, Horny HP et al (1996) Transplantation of a human ovarian cystadenocarcinoma into severe combined immunodeficient (SCID) mice—formation of metastases without significant alteration of the tumour cell phenotype. Int J Exp Pathol 77:219–227

    Article  PubMed  CAS  Google Scholar 

  11. Yoshida Y, Okamura T, Shirakusa T (1993) An immunohistochemical study of Helix pomatia agglutinin binding on carcinomas of the esophagus. Surg Gynecol Obstet 177:299–302

    PubMed  CAS  Google Scholar 

  12. Yoshida Y, Okamura T, Yano K et al (1994) Silver stained nucleolar organizer region proteins and Helix pomatia agglutinin immunostaining in esophageal carcinoma: correlated prognostic factors. J Surg Oncol 56:116–121

    Article  PubMed  CAS  Google Scholar 

  13. Takahashi H, Oyaizu T, Fujita Y et al (1994) Lectin-binding profiles in MNNG-induced shrew esophageal carcinomas. Anticancer Res 14:1569–1572

    PubMed  CAS  Google Scholar 

  14. Schumacher U, Higgs D, Loizidou M et al (1994) Helix pomatia agglutinin binding is a useful prognostic indicator in colorectal carcinoma. Cancer 74:3104–3107

    Article  PubMed  CAS  Google Scholar 

  15. Shiraishi T, Atsumi S, Yatani R (1992) Comparative study of prostatic carcinoma bone metastasis among Japanese in Japan and Japanese Americans and whites in Hawaii. Adv Exp Med Biol 324:7–16

    PubMed  CAS  Google Scholar 

  16. Brooks SA, Leathem AJ, Camplejohn RS et al (1993) Markers of prognosis in breast cancer—the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy. Breast Cancer Res Treat 25:247–256

    Article  PubMed  CAS  Google Scholar 

  17. Wu AM, Sugii SJ (1998) Differential binding properties of Ga1NAc and/or Ga1 specific lectins. Adv Exp Med Biol 228:205–263

    Google Scholar 

  18. Springer GF (1989) Tn epitope (N-acetyl-D-galactosamine alpha-O-serine/threonine) density in primary breast carcinoma: a functional predictor of aggressiveness. Mol Immunol 26:1–5

    Article  PubMed  CAS  Google Scholar 

  19. Ito N, Imai S, Haga S et al (1996) Localization of binding sites of Ulex europaeus I, Helix pomatia and Griffonia simplicifolia I-B4 lectins and analysis of their backbone structures by several glycosidases and poly-N-acetyllactosamine-specific lectins in human breast carcinomas. Histochem Cell Biol 106:331–339

    PubMed  CAS  Google Scholar 

  20. Sanchez JF, Lescar J, Chazalet V et al (2006) Biochemical and structural analysis of Helix pomatia agglutinin. A hexameric lectin with a novel fold. J Biol Chem 281:20171–20180

    Article  PubMed  CAS  Google Scholar 

  21. Brooks SA, Carter TM (2001) N-acetylgalactosamine, N-acetylglucosamine and sialic acid expression in primary breast cancers. Acta Histochem 103:37–51

    Article  PubMed  CAS  Google Scholar 

  22. Sobrinho-Simoes M, Damjanov I (1986) Lectin immunohistochemistry of papillary and follicular carcinoma of the thyroid gland. Arch Pathol Lab Med 110:722–729

    PubMed  CAS  Google Scholar 

  23. Sasano H, Rojas M, Silverberg SG (1989) Analysis of lectin binding in benign and malignant thyroid nodules. Arch Pathol Lab Med 113:186–189

    PubMed  CAS  Google Scholar 

  24. Babal P, Janega P, Cerna A et al (2006) Neoplastic transformation of the thyroid gland is accompanied by changes in cellular sialylation. Acta Histochem 108:133–140

    Article  PubMed  CAS  Google Scholar 

  25. Krzeslak A, Pomorski L, Gaj Z et al (2003) Differences in glycosylation of intracellular proteins between benign and malignant thyroid neoplasms. Cancer Lett 196:101–107

    Article  PubMed  CAS  Google Scholar 

  26. Brooks SA, Wilkinson D (2003) Validation of a simple avidin-biotin detection method for Helix pomatia lectin (HPA) binding as a prognostic marker in cancer. Acta Histochem 105:205–212

    Article  PubMed  CAS  Google Scholar 

  27. Wessel D, Flugge UI (1984) A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem 138:141–143

    Article  PubMed  CAS  Google Scholar 

  28. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259):680–685

    Article  PubMed  CAS  Google Scholar 

  29. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354

    Article  PubMed  CAS  Google Scholar 

  30. Kakeji Y, Maehara Y, Tsujitani S et al (1994) Helix pomatia agglutinin binding activity and lymph node metastasis in patients with gastric cancer. Semin Surg Oncol 10:130–134

    Article  PubMed  CAS  Google Scholar 

  31. Maehara Y, Okuyama T, Kakeji Y et al (1995) A tumour-associated cell-surface glycoprotein accompanying p53 overexpression and higher growth potential for gastric cancer. Br J Cancer 71:999–1002

    Article  PubMed  CAS  Google Scholar 

  32. Schumacher U, Adam E (1997) Lectin histochemical HPA-binding pattern of human breast and colon cancers is associated with metastases formation in severe combined immunodeficient mice. Histochem J 29:677–684

    Article  PubMed  CAS  Google Scholar 

  33. Laack E, Nikbakht H, Peters A et al (2002) Lectin immunohistochemistry of resected adenocarcinoma of the lung: Helix pomatia agglutinin binding is an independent prognostic factor. Am J Pathol 160:1001–1008

    Article  PubMed  Google Scholar 

  34. Brooks SA, Lymboura M, Schumacher U et al (1996) Immunohistochemistry to detect Helix pomatia lectin binding in breast cancer: methodology makes a difference. J Histochem Cytochem 44:519–524

    Article  PubMed  CAS  Google Scholar 

  35. Motoi N, Sakamoto A, Yamochi T et al (2000) Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin. Pathol Res Pract 196:1–7

    PubMed  CAS  Google Scholar 

  36. Jhiang SM, Cho JY, Furminger TL et al (1998) Thyroid carcinomas in RET/PTC transgenic mice. Recent Results Cancer Res 154:265–270

    PubMed  CAS  Google Scholar 

  37. Jhiang SM (2000) The RET proto-oncogene in human cancers. Oncogene 19:5590–5597

    Article  PubMed  CAS  Google Scholar 

  38. Xing M (2005) BRAF mutation in thyroid cancer. Endocr Relat Cancer 12:245–262

    Article  PubMed  CAS  Google Scholar 

  39. Trovisco V, Soares P, Sobrinho-Simoes M (2006) B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas. Hum Pathol 37:781–786

    Article  PubMed  CAS  Google Scholar 

  40. Dwek MV, Ross HA, Streets AJ et al (2001) Helix pomatia agglutinin lectin-binding oligosaccharides of aggressive breast cancer. Int J Cancer 95:79–85

    Article  PubMed  CAS  Google Scholar 

  41. Kim YJ, Varki A (1997) Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J 14:569–576

    Article  PubMed  CAS  Google Scholar 

  42. Franceschi M, Kusic Z, Franceschi D et al (1996) Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 37:446–451

    PubMed  CAS  Google Scholar 

  43. Whitley RJ, Ain KB (2004) Thyroglobulin: a specific serum marker for the management of thyroid carcinoma. Clin Lab Med 24:29–47

    Article  PubMed  Google Scholar 

  44. Brooks SA, Hall DM, Buley I (2001) GalNAc glycoprotein expression by breast cell lines, primary breast cancer and normal breast epithelial membrane. Br J Cancer 85:1014–1022

    Article  PubMed  CAS  Google Scholar 

  45. Schumacher U, Adam E, Brooks SA et al (1995) Lectin-binding properties of human breast cancer cell lines and human milk with particular reference to Helix pomatia agglutinin. J Histochem Cytochem 43:275–281

    Article  PubMed  CAS  Google Scholar 

  46. Xing M (2010) Prognostic utility of BRAF mutation in papillary thyroid cancer. Mol Cell Endocrinol 321:86–93

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrine and General Surgery, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK

    Rajeev Parameswaran & Gregory Sadler

  2. School of Life Sciences, Oxford Brookes University, Gipsy Lane, Headington, Oxford, OX3 0BP, UK

    Susan Brooks

Authors
  1. Rajeev Parameswaran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gregory Sadler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susan Brooks
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rajeev Parameswaran.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parameswaran, R., Sadler, G. & Brooks, S. Helix pomatia Agglutinin Binding Glycoproteins in Thyroid Tumors. World J Surg 35, 2219–2227 (2011). https://doi.org/10.1007/s00268-011-1196-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-011-1196-2

Keywords

Search

Navigation